Market Place
Sourcing Support
Enforcement Report - Week of February 1, 2023
01 Feb 2023 //
FDA
Enforcement Report - Week of February 2, 2022
02 Feb 2022 //
FDA
Sandoz completes acquisition of GSK’s cephalosporin business
11 Oct 2021 //
PMLIVE
Pfizer snaps up antibiotics maker Arixa and its oral Avycaz follow-up
23 Oct 2020 //
FIERCE BIOTECH
Enforcement Report - Week of May 6, 2020
06 May 2020 //
FDA
Sihuan Pharm Becomes the First Chinese Company that was Granted Approval for
07 May 2019 //
PR NEWSWIRE
White House Pharmacy Receives Form 483
22 Nov 2018 //
FDA
Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer
04 Jun 2018 //
PRESS RELEASE
Allergan’s Avycaz breaks Gram-negative pneumonia antibiotic drought
05 Feb 2018 //
PMLIVE
FDA Approves AVYCAZ® (ceftazidime and avibactam) for the Treatment of Patients
01 Feb 2018 //
PR NEWSWIRE
FDA Accepts Supplemental (sNDA) filing for AVYCAZ® (ceftazidime and avibactam)
02 Oct 2017 //
PR NEWSWIRE
Allergan`s sNDA for avycaz gets US FDA nod to include new phase III data
01 Feb 2017 //
PHARMABIZ
Aptevo says production issues for hemophilia B treatment Ixinity appear resolved
04 Jan 2017 //
FIERCE PHARMA
US FDA accepts Allergan`s sNDA for Avycaz
13 Oct 2016 //
PHARMABIZ
FDA Accepts Supplemental New Drug Application for AVYCAZ
11 Oct 2016 //
PR NEWSWIRE
Hospira Healthcare India Private Limited Fails EDQM Inspection
18 Aug 2016 //
EDQM
EU clears AstraZeneca’s new antibiotic
30 Jun 2016 //
PHARMATIMES
Allergan Announces FDA Approval of sNDA for AVYCAZ® (ceftazidime and avibactam)
24 Jun 2016 //
PR NEWSWIRE
Ceftazidime-avibactam in Gram-negative bacteria multidrug resistant
11 Apr 2016 //
PR NEWSWIRE
FDA Accepts and Grants Priority Review for AVYCAZ® sNDA
24 Feb 2016 //
PR NEWSWIRE
FDA cautions about dose confusion and medication error with Avycaz
23 Sep 2015 //
FDA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.